Wellcome Trust and drug giants fund gene marker databaseBMJ 1999; 318 doi: https://doi.org/10.1136/bmj.318.7191.1093 (Published 24 April 1999) Cite this as: BMJ 1999;318:1093
- Richard Woodman
A two year, £28m ($44.8m) initiative to create a high quality map of genetic markers, which will be available to everyone without charge, has been launched by the Wellcome Trust together with a group of leading pharmaceutical companies and academic centres.
The collaborative effort, called the SNP Consortium, will seek to identify and analyse single nucleotide polymorphisms involved in disease processes so that safer and more effective drugs can be developed.
Single nucleotide polymorphisms, sometimes called “snips,” are common variations that occur …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial